The FDA has recalled Zantac as it has been linked to cancer, birth defects, and even death.
Zantac, generically known as ranitidine, is a popular medicine used to treat heart burn, indigestion, and gastrointestinal disorders. On April 1, the FDA recalled all ranitidine products, as research shows it can produce high levels of Nitrosodimethylamine (NDMA), a cancer-causing carcinogen. Studies have also found that NDMA can cause birth defects in mice, and many believe that this could happen to a human fetus if a mother took Zantac during pregnancy.
Individuals are filing cases against Zantac’s manufacturer, Sanofi, claiming that they were exposed to extremely high levels of NDMA. You may be entitled to a substantial settlement if you took Zantac and your child was born with birth defects, or if you were diagnosed with any of the following:
The International Agency for Research on Cancer (IARC) and the World Health Organization have stated that NDMA is “ probably carcinogenic to humans.” Due to the toxic nature of NDMA, the FDA advises people not to consume more than 96 nanograms of NDMA a day. Previous testing found that there are more than 3,000,000 ng in one Zantac pill.
Zantac’s manufacturer, Sanofi, had the obligation to warn users of the drug’s possibly harmful side effects, but it waited until after the FDA conducted research on it and advised of its health risks. Hold Sanofi accountable for marketing a product that contains a cancer-causing chemical. File your claim today.